超声证实的附着点骨赘与银屑病关节炎附着点影像学进展相关
这项前瞻性研究纳入83例银屑病关节炎患者,在基线、6个月和12个月对14个附着点进行临床和超声评估,基线和12个月行X线检查。多因素回归显示基线超声骨赘评分可解释12个月X线评分48.6%的变异。
要点
- 基线超声证实的附着点骨赘与12个月附着点影像学进展独立相关。
- 其他超声参数(侵蚀、灰阶、能量多普勒)未预测附着点影像学进展。
- 进展组患者更年轻、病程更短且6个月临床疾病活动度更低。
核心结论
- 附着点影像学进展与年龄、病程及基线超声证实的附着点骨赘相关。
- 其他超声参数均未预测附着点影像学进展。
研究设计与样本
- 前瞻性研究连续纳入银屑病关节炎患者,基线、6个月和12个月对14个附着点行临床和超声评估,基线和12个月行X线检查。
- 基线共检查83例患者,其中43例(51.8%)具有完整临床、超声和X线数据。
主要发现
- 进展组较无进展组更年轻(49.6 vs 59.3,P=0.005)、病程更短(9.7 vs 17.9年,P=0.015)。
- 进展组6个月临床疾病活动度更低(DAPSA 6.7 vs 17.0,P=0.018)。
- 无进展组基线超声附着点骨赘评分高于进展组(20 vs 15,P<0.05)。
- 多因素回归显示基线超声骨赘评分可解释12个月X线评分48.6%的变异(RegcoeffB=0.827,P=0.000)。
关键数值与推荐
- 超声结构评估包括侵蚀和骨赘;炎症评估包括灰阶(0-32)和能量多普勒(0-14),全局超声评分范围0-140。
- X线评估附着点骨赘和侵蚀,评分范围0-56。
临床怎么用
- 对银屑病关节炎患者,基线超声附着点骨赘评估有助于识别附着点影像学进展风险较高的患者。
局限性
- 仅43例(51.8%)患者具有完整临床、超声和X线数据,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this prospective study was to examine whether ultrasound or clinical abnormalities at enthesal sites predict radiographic progression at entheses in psoriatic arthritis (PsA). METHODS: Consecutive PsA patients were included and subjected to clinical and ultrasound assessments at 14 entheses at baseline, 6 and 12 months. Radiographs were performed at 0 and 12 months. By US, we investigated structural (erosions, osteophytes) and inflammatory changes [grey scale (0-32) and power Doppler (0-14, range global ultrasound score 0-140)], and radiographs were evaluated for enthesophytes and erosions (score range 0-56). Multivariate regression models were conducted to identify the possible association of clinical and ultrasound findings with radiographic progression. RESULTS: We examined 83 patients at baseline, of whom 43 (51.8%) had complete clinical, ultrasound and X-ray data. Twenty-four of 43 patients (55.8%) developed radiographic progression of entheses. These patients were younger (49.6 vs 59.3, P =0.005), had shorter disease duration (9.7 vs 17.9 years, P=0.015) and lower clinical disease activity at 6-months [disease activity in psoriatic arthritis (DAPSA) 6.7 vs 17.0, P=0.018] as compared with patients without progression. Non-progressors had higher ultrasound enthesophyte scores at baseline than progressors (20 vs 15, P<0.05). The multivariate regression analysis revealed that 48.6% of the variance of the X-ray score at 12-months follow-up (RegcoeffB = 0.827, P=0.000) could be explained by the baseline US enthesophyte score. CONCLUSION: Our data indicate that radiographic progression at entheses is linked with age, disease duration and ultrasound verified enthesophytes at baseline. No other ultrasound parameter predicted radiographic progression at entheses.
引用
- Lackner A, Heber D, Bosch P, et al. Ultrasound verified enthesophytes are associated with radiographic progression at entheses in psoriatic arthritis. Rheumatology (Oxford). 2020. PMID: 32091097. doi:10.1093/rheumatology/keaa028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。